sheath fluid plus (Bio-Rad)
Bio-Rad is a verified supplier 
Bio-Rad manufactures this product 
93
Structured Review
Bio-Rad
sheath fluid plus
Sheath Fluid Plus, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluid/Instrument+Sheath+Fluid/pm42805575-153-10-27
Average 93 stars, based on 61 article reviews
Sheath Fluid Plus, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 61 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluid/Instrument+Sheath+Fluid/pm42805575-153-10-27
Average 93 stars, based on 61 article reviews
sheath fluid plus - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
other:Article Title: Exosomal microRNA-506 inhibits biological activity of lung adenocarcinoma cells and increases sensitivity to cisplatin-based hyperthermia. Article Snippet: Exosomal microRNAs (miRNAs) play a vital role in the occurrence and development of lung adenocarcinoma (LUAD).. Based on the bioinformatics analyses, the current study sought to explore the effects of exosomal miR506 on LUAD cell biology and the efficacy of cisplatin (CDDP)-based hyperthermia (HT).. After sample preparation, we identified decreased miR-506 and elevated ATAD2. Protein Concentration:Article Title: Comparative pulmonary toxicity of inhaled nickel nanoparticles; role of deposited dose and solubility. Article Snippet: In this pilot study, we investigated which physicochemical properties of nickel hydroxide nanoparticles (nano-NH) were mainly responsible in inducing pulmonary toxicity.. First, we studied the role of nickel ions solubilized from nano-NH by comparing the toxic effects of nano-NH to those of readily soluble nickel sulfate nanoparticles (nano-NS).. Additionally, to test whether there was a non-specific stress response due to particle morphology, we compared the toxicity of nano-NH with that of carbon nanoparticles (nano-C) and titanium dioxide nanoparticles (nano-Ti), both of which had similar physical properties such as particle size and shape, to nano-NH. 96 Well Plates:Article Title: Doxorubicin-based ENO1 targeted drug delivery strategy enhances therapeutic efficacy against colorectal cancer. Article Snippet: Alpha-enolase (ENO1), a multifunctional protein with carcinogenic properties, has emerged as a promising cancer biomarker because of its differential expression in cancer and normal cells.. On the basis of this characteristic, we designed a cell-targeting peptide that specifically targets ENO1 and connected it with the drug doxorubicin (DOX) by aldehyde–amine condensation.. A surface plasmon resonance (SPR) assay showed that the affinity for ENO1 was stronger (KD = 2.5 μM) for the resulting cell-targeting drug, DOX-P, than for DOX. Incubation:Article Title: Doxorubicin-based ENO1 targeted drug delivery strategy enhances therapeutic efficacy against colorectal cancer. Article Snippet: Alpha-enolase (ENO1), a multifunctional protein with carcinogenic properties, has emerged as a promising cancer biomarker because of its differential expression in cancer and normal cells.. On the basis of this characteristic, we designed a cell-targeting peptide that specifically targets ENO1 and connected it with the drug doxorubicin (DOX) by aldehyde–amine condensation.. A surface plasmon resonance (SPR) assay showed that the affinity for ENO1 was stronger (KD = 2.5 μM) for the resulting cell-targeting drug, DOX-P, than for DOX. CCK-8 Assay:Article Title: Doxorubicin-based ENO1 targeted drug delivery strategy enhances therapeutic efficacy against colorectal cancer. Article Snippet: Alpha-enolase (ENO1), a multifunctional protein with carcinogenic properties, has emerged as a promising cancer biomarker because of its differential expression in cancer and normal cells.. On the basis of this characteristic, we designed a cell-targeting peptide that specifically targets ENO1 and connected it with the drug doxorubicin (DOX) by aldehyde–amine condensation.. A surface plasmon resonance (SPR) assay showed that the affinity for ENO1 was stronger (KD = 2.5 μM) for the resulting cell-targeting drug, DOX-P, than for DOX. |